Abstract:Abstract Polyglutamine (polyQ) expansion of proteins can trigger protein misfolding and amyloid-like aggregation, which thus lead to severe cytotoxicities and even the respective neurodegenerative diseases. However, why polyQ aggregation is toxic to cells is not fully elucidated. Here, we took the fragments of polyQ-expanded (PQE) ataxin-7 (Atx7) and huntingtin (Htt) as models to investigate the effect of polyQ aggregates on the cellular proteostasis of endogenous ataxin-3 (Atx3), a protein that frequently appears in diverse inclusion bodies. We found that PQE Atx7 and Htt impair the cellular proteostasis of Atx3 by reducing its soluble as well as total Atx3 level but enhancing formation of the aggregates. Expression of these polyQ proteins promotes proteasomal degradation of endogenous Atx3 and accumulation of its aggregated form. Then we verified that the co-chaperone HSJ1 is an essential factor that orchestrates the balance of cellular proteostasis of Atx3; and further discovered that the polyQ proteins can sequester HSJ1 into aggregates or inclusions in a UIM domain-dependent manner. Thereby, the impairment of Atx3 proteostasis may be attributed to the sequestration and functional loss of cellular HSJ1. This study deciphers a potential mechanism underlying how PQE protein triggers proteinopathies, and also provides additional evidence in supporting the hijacking hypothesis that sequestration of cellular interacting partners by protein aggregates leads to cytotoxicity or neurodegeneration.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: Why are the aggregates formed by proteins containing expanded polyglutamine (polyQ) fragments toxic to cells? In particular, how do they lead to the occurrence of neurodegenerative diseases by affecting intracellular proteostasis? Specifically, the authors selected fragments of polyQ - expanded ataxin - 7 (Atx7) and huntingtin (Htt) as models to study how these polyQ aggregates affect the cellular proteostasis of endogenous ataxin - 3 (Atx3). Atx3 is a protein commonly found in multiple inclusion bodies, and its abnormal function is associated with spinocerebellar ataxia type 3 (SCA3). ### Main problem summary: 1. **How do polyQ protein aggregates affect the cellular proteostasis of Atx3?** - The study found that polyQ - expanded Atx7 and Htt can disrupt the cellular proteostasis of Atx3 by reducing the soluble fraction of Atx3 and increasing its insoluble aggregates. 2. **What is the specific mechanism of this toxic effect?** - The authors found that polyQ proteins can reduce the total level of Atx3 by promoting its proteasomal degradation and enhance the formation of Atx3 aggregates. - Further research indicates that polyQ proteins can trap the co - chaperone protein HSJ1 into aggregates, resulting in the loss of HSJ1 function and thus affecting the proteostasis of Atx3. 3. **What role does HSJ1 play in this process?** - HSJ1 is an important regulator that maintains the protein level of Atx3 through its UIM domain. When HSJ1 is trapped by polyQ proteins, it will lead to an increase in the proteasomal degradation of Atx3, thereby reducing the level of its soluble fraction. ### Conclusion: This study reveals the potential mechanism by which polyQ - expanded proteins cause damage to Atx3 proteostasis by trapping the co - chaperone protein HSJ1, providing new clues for understanding how polyQ protein pathological aggregates trigger cytotoxicity and neurodegenerative diseases. ### Key formula and symbol explanations: - **polyQ**: Polyglutamine - **Atx3**: Ataxin - 3 - **HSJ1**: Homo sapiens J - domain protein - **UIM**: Ubiquitin - interacting motif Through these research results, the authors support the hypothesis that protein aggregates cause cytotoxicity and neurodegenerative diseases by trapping key cellular components such as HSJ1.

PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates

Co-aggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis

Structural and dynamic studies reveal that the Ala-rich region of ataxin-7 initiates α-helix formation of the polyQ tract but suppresses its aggregation

Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity

Endosome mediated nucleocytoplasmic trafficking and endomembrane allocation is crucial to polyglutamine toxicity

The BAG2 and BAG5 Proteins Inhibit the Ubiquitination of Pathogenic Ataxin3-80Q.

Overexpression of F0f1-Atp Synthase Alpha Suppresses Mutant Huntingtin Aggregation and Toxicity in Vitro

Single Homopolypeptide Chains Collapse Into Mechanically Rigid Conformations

Ataxin‐2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling

Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation

Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition

Polyglutamine Expansion Alters the Dynamics and Molecular Architecture of Aggregates in Dentatorubropallidoluysian Atrophy

Soluble N-terminal Fragment of Mutant Huntingtin Protein Impairs Mitochondrial Axonal Transport in Cultured Hippocampal Neurons.

Loss of FIC-1-mediated AMPylation activates the UPR and upregulates cytosolic HSP70 chaperones to suppress polyglutamine toxicity

Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens

Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington's disease

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

Autophagy preferentially degrades non-fibrillar polyQ aggregates

PLK2-mediated phosphorylation of SQSTM1 S349 promotes aggregation of polyubiquitinated proteins upon proteasomal dysfunction

Essential sequence of the N-terminal cytoplasmic localization-related domain of huntingtin and its effect on huntingtin aggregates